Back to search
Prevention of Ischemic Stroke
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prevention of Ischemic Stroke trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Prevention of Ischemic Stroke trials you may qualify forThe goal of this observational study is to use a genetic test to help doctors prescribe the most effective medications after a patient has a stroke. One type of…
DAN-ZOSTER is a nationwide randomized study investigating whether vaccination against herpes zoster (shingles) can reduce the risk of cardiovascular disease and…
Patients with atrial fibrillation (AF) who have had a prior stroke are at very high risk of recurrent ischemic stroke. About 40% of these strokes are due to lar…
Patent foramen ovale (PFO) is an important mechanism of embolic stroke of undetermined source (ESUS). Current guidelines recommend PFO closure for high-risk PFO…
The goal of this study is to test if Savvy, a multimodal intervention (consisting of psychological exercises, a weekly pill organizer, and a text message remind…
This randomized controlled trial aims to evaluate the effects of task-specific training with and without biofeedback compared to conventional physical therapy o…
The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.
The aim of this trial is to assess the safety and efficacy of conestat alfa (Ruconest®, Pharming Technologies B.V.) on renal and cerebral ischemic events in pat…